May 2, 2020
Revance, Mylan Biosimilar to Botox postpon program decision
Revance, Mylan Biosimilar to Botox postpon program decision to aftr April
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Revance Therapeutics
September 25, 2019
Revance to Participate in the 2019 Cantor Global Healthcare Conference
NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications,…
April 8, 2019
SAKURA 3 Trial Results Presented on Podium at World’s Largest Medical Aesthetic Conference
Unprecedented clinical results for DaxibotulinumtoxinA for Injection(DAXI), Revance’s long-acting neuromodulator, were highlighted at the 17thAesthetics & Anti-Aging Medical World Congress in Monte-Carlo